TY - JOUR
T1 - Butyrate modulates oxidative stress in the colonic mucosa of healthy humans.
AU - Hamer, H.M.H.
AU - Jonkers, D.M.
AU - Bast, A.
AU - Vanhoutvin, S.A.
AU - Fischer, M.A.
AU - Kodde, A.
AU - Troost, F.J.
AU - Venema, K.
AU - Brummer, R.J.
PY - 2009/1/1
Y1 - 2009/1/1
N2 - BACKGROUND & AIMS: Butyrate, a short-chain fatty acid produced by colonic microbial fermentation of undigested carbohydrates, has been implicated in the maintenance of colonic health. This study evaluates whether butyrate plays a role in oxidative stress in the healthy colonic mucosa. METHODS: A randomized, double blind, cross-over study with 16 healthy volunteers was performed. Treatments consisted of daily rectal administration of a 60ml enema containing 100mM sodium butyrate or saline for 2weeks. After each treatment, a blood sample was taken and mucosal biopsies were obtained from the sigmoid colon. In biopsies, the trolox equivalent antioxidant capacity, activity of glutathione-S-transferase, concentration of uric acid, glutathione (GSH), glutathione disulfide and malondialdehyde, and expression of genes involved in GSH and uric acid metabolism was determined. Secondary outcome parameters were CRP, calprotectin and intestinal fatty acid binding protein in plasma and histological inflammatory scores. RESULTS: Butyrate treatment resulted in significantly higher GSH (p<0.05) and lower uric acid (p<0.01) concentrations compared to placebo. Changes in GSH and uric acid were accompanied by increased and decreased expression, respectively, of their rate limiting enzymes determined by RT-PCR. No significant differences were found in other parameters. CONCLUSIONS: This study demonstrated that butyrate is able to beneficially affect oxidative stress in the healthy human colon. AD - TI Food and Nutrition, Wageningen, the Netherlands; Department of Internal Medicine, Division of Gastroenterology-Hepatology, Nutrim, Maastricht University, Maastricht, the Netherlands.
AB - BACKGROUND & AIMS: Butyrate, a short-chain fatty acid produced by colonic microbial fermentation of undigested carbohydrates, has been implicated in the maintenance of colonic health. This study evaluates whether butyrate plays a role in oxidative stress in the healthy colonic mucosa. METHODS: A randomized, double blind, cross-over study with 16 healthy volunteers was performed. Treatments consisted of daily rectal administration of a 60ml enema containing 100mM sodium butyrate or saline for 2weeks. After each treatment, a blood sample was taken and mucosal biopsies were obtained from the sigmoid colon. In biopsies, the trolox equivalent antioxidant capacity, activity of glutathione-S-transferase, concentration of uric acid, glutathione (GSH), glutathione disulfide and malondialdehyde, and expression of genes involved in GSH and uric acid metabolism was determined. Secondary outcome parameters were CRP, calprotectin and intestinal fatty acid binding protein in plasma and histological inflammatory scores. RESULTS: Butyrate treatment resulted in significantly higher GSH (p<0.05) and lower uric acid (p<0.01) concentrations compared to placebo. Changes in GSH and uric acid were accompanied by increased and decreased expression, respectively, of their rate limiting enzymes determined by RT-PCR. No significant differences were found in other parameters. CONCLUSIONS: This study demonstrated that butyrate is able to beneficially affect oxidative stress in the healthy human colon. AD - TI Food and Nutrition, Wageningen, the Netherlands; Department of Internal Medicine, Division of Gastroenterology-Hepatology, Nutrim, Maastricht University, Maastricht, the Netherlands.
U2 - 10.1016/j.clnu.2008.11.002
DO - 10.1016/j.clnu.2008.11.002
M3 - Article
SN - 0261-5614
VL - 28
SP - 88
EP - 93
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 1
ER -